Intrinsic Value of S&P & Nasdaq Contact Us

Phoenix Biotech Acquisition Corp. PBAX NASDAQ

NASDAQ Global Market • Financial Services • Shell Companies • US • USD

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PBAX

Phoenix Biotech Acquisition Corp. (PBAX) has a market capitalization of $36.47M and trades at $5.85. The 52-week range is 4.12-12.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -26.6, Earnings Per Share (EPS) of $-0.22.

The stock has a beta of 0.04, operates in the Financial Services sector.

Trading Data
Current Price$5.85
52-Week Range4.12-12.8
Volume6.12K
Avg Volume (30D)8.08K
Market Cap$36.47M
Beta (1Y)0.04
Company
IPO Date2021-11-30
CEOChristopher B. Ehrlich
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS71902K1051
CUSIP71902K105
Income (Latest Year)
EBITDA$-16.2M
Operating Income$-16.2M
Net Income$-11.09M
EPS$-0.22
EPS Diluted$-0.22
Shares Outstanding$49.68M
Balance Sheet (Latest Year)
Total Assets$6.21M
Current Assets$3.71M
Cash & ST Investments$3.33M
Total Liabilities$8.1M
Total Debt$1.58M
Net Debt$-1.75M
Valuation Ratios
P/E Ratio-26.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message